• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Coagulation & Plasma Transfusion

Covid-19 Convalescent Plasma Neutralizes Variants of Concern Including Omicron

Recent omicron variants of the SARS-CoV-2 virus have at least 32 changes in the spike protein relative to the original…

March 9, 2022

Hospitalized COVID-19 Patients with Early Disease and Preexisting Conditions May Benefit from Convalescent Plasma

Understanding which patients with COVID-19 benefit the most from COVID-19 convalescent plasma (CCP) may help determine how convalescent plasma may…

February 2, 2022

Outpatient COVID-19 Convalescent Plasma Reduces Hospitalizations

While more than 500,000 units of COVID-19 convalescent plasma (CCP) have been transfused in the United States alone, the use…

December 21, 2021

Cold-Stored Group O Whole Blood Use in Severely Injured Patients

Trauma patients have a severe risk of hemorrhagic shock, and managing their platelet count is crucial for their survival.  In…

December 14, 2021

FDA Update about Bacterial Contamination of Platelets

The United Stated Food and Drug Administration (FDA) issued guidance to reduce the risk of septic transfusion reactions associated with…

December 8, 2021

RBC and Plasma Transfusions Decreased in the U.S. (2015-2018)

Blood transfusions are one of the most common medical procedures in hospitalized patients, and robust data from randomized clinical trials…

September 28, 2021

REDS-III Study Highlights Need for Pediatric Oncology Transfusion Guidelines

  Pediatric hematology/oncology patients receive a significant proportion of pediatric transfusions.  Data, however, are limited guiding clinical decisions for transfusions…

September 22, 2021

Convalescent Plasma Does Not Prevent Disease Progression in COVID-19 Emergency Room Patients

Very few therapeutic options are available early in infectious disease epidemics with the exception of convalescent plasma.  In August 2020,…

August 24, 2021

Pilot Randomized Clinical Trial Finds No Benefit for Prophylactic Plasma Transfusions

Annually, 2.4 million units of plasma are transfused in the U.S.  Approximately a quarter to half of plasma transfusions are…

July 27, 2021

HLA Induced Refractoriness to Platelet Transfusions

Platelet transfusion refractoriness (PTR) is usually caused by non-immune platelet consumption but can also be caused by immune-mediated platelet destruction. …

June 16, 2021

  • « Go to Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Interim pages omitted …
  • Page 9
  • Go to Next Page »

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley